How much funding has Absco Therapeutics raised?

Absco Therapeutics has disclosed $7M raised across 2 rounds.

Where is Absco Therapeutics headquartered?

Absco Therapeutics is headquartered in Allston, US.

Absco Therapeutics

Allston, US · Founded 2024 · Delaware corporation

Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.

Biotech Healthtech Medical Devices

Founders & leadership

Stephen LindermanNamed on SEC filing

Carlo Giovanni TraversoNamed on SEC filing

Avik SominFounder and CEO

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 2 rounds · 2024–2025

▶$5MraisedAug 2025 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Stephen LindermanExecutive Officer, Director
Carlo Giovanni TraversoDirector
Avik SomDirector

Offering amount: $5M
Amount sold: $5M
First sale: Aug 2025
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedMay 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Avik SomDirector
Carlo Giovanni TraversoDirector
Stephen LindermanExecutive Officer, Director

Offering amount: $2M
Amount sold: $2M
First sale: May 2024
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

IQVIA3 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Companies competing with Absco Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Absco Therapeutics do?: Absco Therapeutics develops a drug delivery platform based on thermogelling polymers that shift from liquid to solid at body temperature to form controlled-release depots for sustained, on-target therapy. Its lead candidate ABS005 is a non-surgical intralesional treatment for high-grade cervical intraepithelial neoplasia (CIN2/3), with the platform targeting cancers and precancers.
How much funding has Absco Therapeutics raised?: Absco Therapeutics has disclosed $7M raised across 2 rounds.
Where is Absco Therapeutics headquartered?: Absco Therapeutics is headquartered in Allston, US.